In this Q&A, Prof Pierce Chow of the National Cancer Centre Singapore discusses the epidemiology of liver disease in Asia Pacific; key considerations around the clinical management of common liver diseases like HBV, HCV, fatty liver and HCC; and the critical role of diagnostics in ensuring early detection and effective treatment.
- [00:09] – Prof Chow’s current roles
- [00:57] – Main risk factors for liver cancer in Asia Pacific
- [03:25] – Reasons why HBV is so common in Asia Pacific
- [04:42] – Liver cancer burden in Asia Pacific
- [06:46] – Best approaches to HCC surveillance
- [08:10] – Barriers to accessing HCC surveillance services
- [10:36] – Digital tools that improve HCC surveillance services
- [11:32] – Key treatments available for liver cancer patients
- [14:44] – Lab-clinician collaboration opportunities in liver cancer care
- [15:46] – Role of policy makers in liver cancer screening and care
Watch the full Q&A below (click the buttons on the play bar to jump to any specific segment that interests you).
